Search for Clinical Trial Results

Sponsored By

Scleroderma, Systemic - 8 Studies Found

Status Study
Completed Study Name: Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis
Condition: Scleroderma, Systemic
Date: 2006-07-03
Interventions: Drug: High-dose intravenous immunoglobulin (Venoglobulin-IH)
Recruiting Study Name: A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Condition: Scleroderma, Systemic
Date: 2015-10-08
Interventions:
  • Drug: Nintedanib
  • Drug: Placebo
Completed Study Name: Imatinib in Systemic Sclerosis
Condition: Scleroderma, Systemic
Date: 2007-07-24
Interventions: Drug: Imatinib mesylate 100 mg orally daily increased by 100 mg/day every 2 weeks to maximum of 400 mg d
Recruiting Study Name: Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis
Condition: Scleroderma, Systemic
Date: 2015-12-09
Interventions: Other: blood samples one blood sample will be done for dos
Not yet recruiting Study Name: The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis
Condition: Scleroderma, Systemic
Date: 2015-06-15
Interventions: Drug: bosentan 62.5 mg oral twice daily for 4 weeks, then 125 mg oral twice daily.
Not yet recruiting Study Name: Platelet Gel in Systemic Sclerosis
Condition: Scleroderma, Systemic
Date: 2007-04-19
Interventions: Drug: Platelet Gel
Recruiting Study Name: Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
Condition: Scleroderma, Systemic
Date: 2015-08-31
Interventions:
  • Drug: Stromal Vascular fraction
  • Drug: Ring
Not yet recruiting Study Name: Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study
Condition: Scleroderma, Systemic
Date: 2017-03-23
Interventions:
  • Drug: Iontophoresis of treprostinil